These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 15239080)

  • 1. Management of hepatorenal syndrome: another piece of the puzzle.
    Ginès P; Guevara M; Perez-Villa F
    Hepatology; 2004 Jul; 40(1):16-8. PubMed ID: 15239080
    [No Abstract]   [Full Text] [Related]  

  • 2. Hepatorenal syndrome: pathophysiology and management.
    Wadei HM; Mai ML; Ahsan N; Gonwa TA
    Clin J Am Soc Nephrol; 2006 Sep; 1(5):1066-79. PubMed ID: 17699328
    [No Abstract]   [Full Text] [Related]  

  • 3. [The therapy of the hepatorenal syndrome in liver cirrhosis].
    Biecker E; Brensing KA; Perz J; Woitas R; Sauerbruch T
    Dtsch Med Wochenschr; 1999 Sep; 124(36):1039-42. PubMed ID: 10506842
    [No Abstract]   [Full Text] [Related]  

  • 4. [Hepatorenal syndrome].
    Bosma JW; van Meyel JJ; Siegert CE
    Ned Tijdschr Geneeskd; 2010; 154():A1355. PubMed ID: 20456764
    [No Abstract]   [Full Text] [Related]  

  • 5. [Therapy of hepatorenal syndrome].
    Walter E
    Praxis (Bern 1994); 1997 Jan; 86(4):102-3. PubMed ID: 9064719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advances in the pathogenesis and treatment of type-1 and type-2 hepatorenal syndrome.
    Arroyo V; Terra C; Ginès P
    J Hepatol; 2007 May; 46(5):935-46. PubMed ID: 17391801
    [No Abstract]   [Full Text] [Related]  

  • 7. Hepatorenal syndrome: a comprehensive overview for the critical care nurse.
    Fleming JN; Abou Abbass A
    Crit Care Nurs Clin North Am; 2010 Sep; 22(3):351-68. PubMed ID: 20691386
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improving prognosis in hepatorenal syndrome.
    McCormick PA
    Gut; 2000 Aug; 47(2):166-7. PubMed ID: 10896904
    [No Abstract]   [Full Text] [Related]  

  • 9. Management of hepatorenal syndrome.
    McCormick PA; Donnelly C
    Pharmacol Ther; 2008 Jul; 119(1):1-6. PubMed ID: 18539334
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Hepatorenal syndrome].
    Saner F; Hertl M; Broelsch CE
    Internist (Berl); 2001 Dec; 42(12):1666-71; quiz 1672-3. PubMed ID: 11793605
    [No Abstract]   [Full Text] [Related]  

  • 11. Medical treatment of hepatorenal syndrome.
    McCormick P; O'Keefe C; Docherty J
    Ir Med J; 1999; 92(7):422, 424. PubMed ID: 10967862
    [No Abstract]   [Full Text] [Related]  

  • 12. [Treatment of hepatorenal syndrome in liver cirrhosis].
    Gülberg V
    Dtsch Med Wochenschr; 2000 Jun; 125(22):712-3. PubMed ID: 10874900
    [No Abstract]   [Full Text] [Related]  

  • 13. [The modern possibilities of the hepato-renal syndrome treatment].
    Blokhina NV; Pasechnik IN
    Khirurgiia (Mosk); 2013; (8):81-5. PubMed ID: 24344429
    [No Abstract]   [Full Text] [Related]  

  • 14. Renal Dysfunction in Cirrhotic Patients.
    Carrion AF; Martin P
    Am J Gastroenterol; 2019 Sep; 114(9):1407-1410. PubMed ID: 31397680
    [No Abstract]   [Full Text] [Related]  

  • 15. Hepatorenal syndrome.
    Cárdenas A; Gines P
    Clin Liver Dis; 2006 May; 10(2):371-85, ix-x. PubMed ID: 16971267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathogenesis and treatment of hepatorenal syndrome.
    Arroyo V; Fernandez J; Ginès P
    Semin Liver Dis; 2008 Feb; 28(1):81-95. PubMed ID: 18293279
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Influence of circulatory dysfunction on the treatment of ascites and hepatorenal syndrome: vasoconstrictor and diuretic drug treatment].
    Torre A; Terra C; Guevara M; Ginès P
    Gastroenterol Hepatol; 2004 Feb; 27 Suppl 1():8-14. PubMed ID: 15195529
    [No Abstract]   [Full Text] [Related]  

  • 18. Pathophysiological basis of pharmacotherapy in the hepatorenal syndrome.
    Møller S; Bendtsen F; Henriksen JH
    Scand J Gastroenterol; 2005 May; 40(5):491-500. PubMed ID: 16036500
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transjugular intrahepatic portosystemic shunt in the management of ascites and hepatorenal syndrome.
    Senzolo M; Cholongitas E; Tibballs J; Burroughs A; Patch D
    Eur J Gastroenterol Hepatol; 2006 Nov; 18(11):1143-50. PubMed ID: 17033432
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapy insight: Management of hepatorenal syndrome.
    Cárdenas A; Ginès P
    Nat Clin Pract Gastroenterol Hepatol; 2006 Jun; 3(6):338-48. PubMed ID: 16741553
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.